sameAs
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in miceRecent advances in Ebolavirus vaccine developmentPersonal protective equipment for filovirus epidemics: a call for better evidenceSulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2Essential role of microfibrillar-associated protein 4 in human cutaneous homeostasis and in its photoprotectionSustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbMonoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigsTransmission of Ebola virus from pigs to non-human primatesEbolavirus Evolution: Past and PresentHypothesis driven development of new adjuvants: short peptides as immunomodulatorsIn vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.Transmission of Ebola viruses: what we know and what we do not knowEbola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015More Challenges From Ebola: Infection of the Central Nervous SystemOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsA Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola VirusEssential role of RAB27A in determining constitutive human skin colorThe ongoing evolution of antibody-based treatments for Ebola virus infection.Essentials of filoviral load quantification.Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular EntryImmunogenicity of novel consensus-based DNA vaccines against avian influenza.Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoproteinPandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferretsCharacterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in MiceEvaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection.Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaquesVirulence differences of closely related pandemic 2009 H1N1 isolates correlate with increased inflammatory responses in ferrets.Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.Prior infection of chickens with H1N1 or H1N2 avian influenza elicits partial heterologous protection against highly pathogenic H5N1.Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza.DNA vaccination protects mice against Zika virus-induced damage to the testesSuccessful Control of Ebola Virus Disease: Analysis of Service Based Data from Rural Sierra Leone.
P50
Q21092172-4A32DD0B-CB77-40D5-822B-3F44380BC332Q22305433-A8B20FB3-37CF-4070-AE10-DD253EE04D20Q22305433-B69F2F63-E730-465E-92A4-2EE755395CE3Q23910096-A5420A55-2B0C-4658-B636-B75A645D5177Q24305426-33EAAA88-E577-4CB4-BFD8-C3F593419268Q24305688-E369E21C-4AAA-40D4-BDBA-0B6204FA986AQ24594601-4469ED59-165A-4920-9614-9E09CFE792F2Q24604416-6EB4D675-58F8-4A71-9054-C6683BACE651Q24612028-94B5C034-DAD1-47DF-8B93-95A12B21FBB1Q26777336-3A853C04-8E3A-44C0-90E7-E8714A9FAA2DQ27023844-BFC34659-F3DB-4EE2-B78A-51FC25890EFDQ27901935-BFF23E44-4F2B-4641-B9FE-7274C9CFA857Q28083565-18338FD3-88CB-4AA8-8597-444EA4DCDE1EQ28390874-C6710D96-D85C-475B-9055-DA90A9E3B303Q28390883-778E1A51-567C-4FE5-8A32-7F0820557CCBQ28474889-ADE4D2DE-2E94-458E-A9B8-42D28641930AQ28552295-EA513B08-CD7A-4C55-9D32-AF0F1CB0A0E5Q28728912-368F1D35-2E0C-4F3D-9670-516BB8B6CEB2Q30235022-C9CE44BD-BD47-4882-B0C4-DE212A33DDB1Q30249651-FF6B2447-1DF9-4DF1-8B16-8B75E6367904Q30276615-7274546F-3605-4DC2-AA7D-96593159149EQ30359911-D2C359D2-FDFA-43D2-9A58-47CC77F68778Q30360232-DF9F3FE9-E8C0-4B05-A472-F7D2AF7C7BA3Q30361326-E2FA75E3-9497-46F4-88CF-D71E2B5AEDD2Q30361939-108EF35F-D5CE-41FC-89D6-640A565CEEA1Q30363661-FF27E39F-F9EF-4CC9-8D71-EB6AA994D116Q30374431-53BDC66C-F753-4A76-B590-22FDA42A7DE3Q30374748-BC32CEA6-2CD1-471A-8081-E3C5D3767B82Q30375073-0F756F65-3582-4B45-9D48-A2F6DAFE6382Q30376925-85809255-8DBE-4998-92D6-FD75E1E3E8F0Q30385847-A6FC356F-C50A-4889-BEC1-485DD1581EDFQ30385999-7B6CEB75-217E-4CC0-8813-A2CC8DEC8D7EQ30393562-9E963CCD-B630-46C5-8E23-15A65E2B58D0Q30396348-1D5F90BB-27D7-4B24-AFF6-DAA6834A5078Q30409317-7C4A6E54-BA15-4086-B0D8-D62BAF8B8217Q30410003-269060F8-3621-457C-830B-093387E88F59Q30414135-D222F395-2D6A-4155-970B-92787EDF0890Q30424773-A5B8472F-5AFB-45E2-8BD5-030CB1C43F45Q30431225-9FBDBEBF-0CA7-4260-A03F-85D5851F6ED4Q30855414-37B99791-55AE-4B34-B238-61BAE841CCD2
P50
description
Canadian microbiologist
@en
microbiologista canadiano
@pt
microbiologiste canadien
@fr
microbiologo canadese
@it
microbiòleg canadenc
@ca
microbiólogo canadense
@gl
microbiólogo canadiense
@es
microbiólogu canadianu
@ast
mikrobiologo kanadarra
@eu
name
Gary Kobinger
@fr
Gary P. Kobinger
@ast
Gary P. Kobinger
@en
Gary P. Kobinger
@es
Gary P. Kobinger
@nl
Gary P. Kobinger
@sl
type
label
Gary Kobinger
@fr
Gary P. Kobinger
@ast
Gary P. Kobinger
@en
Gary P. Kobinger
@es
Gary P. Kobinger
@nl
Gary P. Kobinger
@sl
altLabel
G Kobinger
@en
G P Kobinger
@en
G. Kobinger
@en
G. P. Kobinger
@en
G. P. Kobinger
@fr
Gary Kobinger
@en
Gary P Kobinger
@en
Gary P. Kobinger
@fr
Kobinger G
@en
Kobinger G. P.
@en
prefLabel
Gary Kobinger
@fr
Gary P. Kobinger
@ast
Gary P. Kobinger
@en
Gary P. Kobinger
@es
Gary P. Kobinger
@nl
Gary P. Kobinger
@sl
P106
P108
P69
P108
P1153
57027479500
P19
P21
P27
P31
P345
P496
0000-0003-0612-2298
P6634
gary-kobinger-2aa804149